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St. Catherine University 
St. Paul, MN 
Abstract 
 A three step economical and green alternative has been developed for the synthesis 
of the Donepezil intermediate.  Donepezil is an acetylcholinesterase inhibitor used to 
improve cognitive functions in Alzheimer's disease (AD) patients. AD is a progressive 
neurodegenerative disorder characterized by the loss of memory and dementia and has been 
shown to cause the death of cholinergic neurons and a decline in acetylcholine. Multiple 
studies showed that the use of anticholinergic agents cause amnesia and learning disabilities 
which confirm the importance of acetylcholine against dementia. The use of 
acetylcholinesterase inhibitor inhibits the enzyme acetylcholinesterase increasing, thus, the 
levels of acetylcholine. The three steps synthesis proposed involve the conversion of 3,4-
dimethoxycinnamic acid  to 3-phenylpropionic acid via Pd/C catalysis (1) followed by the 
conversion of  3-phenylpropionic acid to 5,6-dimethoxy-1-inandone via intramolecular 
Friedel-Craft acylation using ethyl acetate for extraction as a green alternative to 
dichloromethane (3). 5,6-dimethoxy-1-inandone and 4-Pyridinecarboxaldehyde were added 
together to form our Donepezil intermediate. 
Background 
Background on Green Chemistry 
NMR Data 
Future Directions 
This research project was funded by Minnesota  Pollution Control 
Agency green chemistry  curriculum initiative.  




Alzheimer’s disease (AD) is a degenerative and progressive disease resulting in the loss of 
memory and decline in activities of daily living (ADLs). Because no cure for AD currently 
exists, the most effective treatment involves slowing down the functional and cognitive 
loss in patients. Donepezil is the most commonly used drug in the market to treat AD, and 
has been proven in several different studies to slow cognitive loss and decline in ADLs. 
Elati and coworkers were able to reduce the cost and waste of production of Donepezil by 
refluxing using p-toluene sulfonic acid in toluene as an alternative to sub-zero temperature 
conditions and the hazardous n-butyl lithium (2). Here, we report a three step synthesis of 
5,6-dimethoxy-indan-1-one to both reduce/maintain the cost of Donepezil synthesis and 
eliminate the use of dichloromethane, a hazardous reagent.  
The first step was the conversion of 3,4-dimethoxycinnamic acid  to 3-phenylpropionic 
acid via Pd/C catalysis followed by the conversion of  3-phenylpropionic acid to 5,6-
dimethoxy-1-inandone via intramolecular Friedel-Craft acylation using ethyl acetate for 
extraction as a green alternative to dichloromethane. The Donepezil intermediate was then 
made by refluxing 5,6-dimethoxy-1-inandone, p-toluene sulfonic acid and 4-
Pyridinecarboxaldehyde in toluene. 
The use of ethyl acetate for extraction was significant because it is less toxic to both 
humans and the environment as well as less expensive when compared to dichloromethane. 
In addition, extraction via dichloromethane unnecessarily produces carcinogenic 




















































































































































































































































































































































Dichloromethane is commonly used as an extraction solvent with an LD 50 of 1600 
mg/kg and has been classified as carcinogenic and toxic to both humans and the 
environment. Ethyl acetate was chosen as a green alternative which is similar in price 
to dichloromethane. Ethyl acetate is less toxic than dichloromethane with an LD 50 of 
5620mg/kg and has not been classified as carcinogenic. The use of dichloromethane 
produces carcinogenic chlorinated water therefore by extracting with ethyl acetate the 
production of unnecessary hazardous waste can be prevented. 
The starting material 3,4-dimethoxycinnamic acid was first converted to 3-
phenylpropionic acid via Pd/C catalysis yielding a white solid (5.3 g, 147% yield). 
The product of step one was confirmed to be 3-phenylpropionic acid by proton NMR 
(see NMR results). NMR also confirmed that excess yield was due to the presence of 
residual methanol. The 3-phenylpropionic acid was then converted to 5,6-dimethoxy-
1-inandone via intramolecular Friedel-Craft acylation using either ethyl acetate or 
dichloromethane for extraction. The ethyl acetate extraction yielded a yellow solid 
(1.132 g, 29% yield) with a byproduct that was purified via crystallization (14.1% 
yield) while the dichloromethane extraction yielded a yellow solid (0.918 g, 31% 
yield). The conversion to dimethoxy-1-inandone was confirmed for both the ethyl 
acetate extraction and the dichloromethane extraction by proton NMR (see NMR 
results). Because the two extractions gave such similar yields, it was reasonably 
concluded that ethyl acetate is a viable alternative to dichloromethane for the purpose 
of this synthesis. The dimethoxy-1-inandone was refluxed with 4-
pyridinecarboxaldehyde and p-toluene sulfuric acid in toluene to give the Donepezil 
intermediate. The dimethoxy-1-inandone product resulting from the ethyl acetate 
extraction yielded a pale yellow solid (0.551 g, 102% yield) with impurities that that 
were purified via crystallization (76.4% yield) while the product resulting from the 
dichloromethane extraction yielded a pale yellow solid (0.501 g, 84% yield) both of 
which were confirmed to be the Donepezil intermediate via proton NMR (see NMR 
results).  
The Donepezil intermediate synthesis shown can be used to proceed with the full 
synthesis of Donepezil. In addition, the substitution of ethyl acetate for 
dichloromethane for the purpose of extraction holds promise for reducing the 
environmental and health impact of other processes. 
The proposed green and economical three step process was successful in synthesizing 
the Donepezil intermediate using ethyl acetate as an alternative to dichloromethane 
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Comparison Parameters  Ethyl Acetate  Dichloromethane  
Hazards  Hazardous when ingested and inhaled. 
Slightly hazardous for eyes and skin   
Very hazardous for eyes and in case of 
ingestion and inhalation. Hazardous for 
skin. Carcinogenic.  
Cost  $34.45/L $26.9/L 
Percent Yield  14.1% 31%  
E Factor  21.5%  88.6%  
Reaction Time, Temp  90° C 90°C  
Product Purity, byproducts  byproduct Minimal Impurities  
Waste produced  150mL ethyl acetate, 100 ml Sat. NaCl, 
traces of anhydrous sodium sulfate 
150mL dichloromethane, 100 ml Sat. 
NaCl, traces of anhydrous sodium sulfate 
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